BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27769358)

  • 1. The exploitation of FRET probes to track bromodomain/histone interactions in cells for bromodomain inhibitors.
    Sasaki K; Yoshida M
    Drug Discov Today Technol; 2016 Mar; 19():51-56. PubMed ID: 27769358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological function and histone recognition of family IV bromodomain-containing proteins.
    Lloyd JT; Glass KC
    J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BET Bromodomain as a Target of Epigenetic Therapy.
    Noguchi-Yachide T
    Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Genetically Encoded FRET Probe to Detect Intranucleosomal Histone H3K9 or H3K14 Acetylation Using BRD4, a BET Family Member.
    Nakaoka S; Sasaki K; Ito A; Nakao Y; Yoshida M
    ACS Chem Biol; 2016 Mar; 11(3):729-33. PubMed ID: 25946208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors.
    Ito T; Umehara T; Sasaki K; Nakamura Y; Nishino N; Terada T; Shirouzu M; Padmanabhan B; Yokoyama S; Ito A; Yoshida M
    Chem Biol; 2011 Apr; 18(4):495-507. PubMed ID: 21513886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.
    Hassan AH; Awad S; Al-Natour Z; Othman S; Mustafa F; Rizvi TA
    Biochem J; 2007 Feb; 402(1):125-33. PubMed ID: 17049045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells.
    Kanno T; Kanno Y; Siegel RM; Jang MK; Lenardo MJ; Ozato K
    Mol Cell; 2004 Jan; 13(1):33-43. PubMed ID: 14731392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodomain inhibitors and cancer therapy: From structures to applications.
    Pérez-Salvia M; Esteller M
    Epigenetics; 2017 May; 12(5):323-339. PubMed ID: 27911230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions.
    Chandrasekaran R; Thompson M
    Biochem Biophys Res Commun; 2007 Apr; 355(3):661-6. PubMed ID: 17320048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
    Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
    J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of live-cell imaging probes for monitoring histone modifications.
    Sasaki K; Ito A; Yoshida M
    Bioorg Med Chem; 2012 Mar; 20(6):1887-92. PubMed ID: 22316554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
    Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
    J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodomain Histone Readers and Cancer.
    Jain AK; Barton MC
    J Mol Biol; 2017 Jun; 429(13):2003-2010. PubMed ID: 27890782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Hewings DS; Rooney TP; Jennings LE; Hay DA; Schofield CJ; Brennan PE; Knapp S; Conway SJ
    J Med Chem; 2012 Nov; 55(22):9393-413. PubMed ID: 22924434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300.
    Ragvin A; Valvatne H; Erdal S; Arskog V; Tufteland KR; Breen K; ØYan AM; Eberharter A; Gibson TJ; Becker PB; Aasland R
    J Mol Biol; 2004 Apr; 337(4):773-88. PubMed ID: 15033350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.
    Dey A; Chitsaz F; Abbasi A; Misteli T; Ozato K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8758-63. PubMed ID: 12840145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.
    Nagashima T; Maruyama T; Furuya M; Kajitani T; Uchida H; Masuda H; Ono M; Arase T; Ozato K; Yoshimura Y
    Mol Hum Reprod; 2007 Mar; 13(3):141-8. PubMed ID: 17267518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.